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Abstract
Introduction: Weighted Blankets (WBs) are a non-pharmacological treatment that
can be used to reduce anxiety, agitation, and insomnia in the inpatient mental
health (MH) setting. Typically, as-needed (PRN) medications are used first-line
with these symptoms. The addition of PRN medications to scheduled medications
can cause drug-drug interactions, dependency, adverse side effects, increased
healthcare costs and reduced medication compliance.
Evidence Summary: WBs are a sensory based intervention (SBI) that provides
deep pressure stimulation (DPS). DPS, an evidence-based intervention, has shown
to reduce stress symptoms and increase calming symptoms. WBs are a form of
DPS used in the inpatient MH setting. WBs have the ability to decrease anxiety,
agitation, and insomnia and provide a promising alternative to PRN medications
being used to control these symptoms.
Gaps: Limited research exists looking at the impact of WB use in the inpatient
adult MH setting. Research specifically regarding the impact of WB on PRN
medication use was not found.
Recommendations for Practice: WBs are a safe treatment that can possibly reduce
anxiety, agitation, and insomnia among MH patients. This treatment may lead to a
decrease in the quantity of PRN medications needed to control these symptoms.
Keywords: weighted blanket, inpatient mental health, anxiety, agitation, insomnia
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Impact of Weighted Blankets on PRN Medication Use in the Inpatient Mental Health
Setting: Review of Literature
Mental health (MH) patients experience symptoms that cause discomfort,
including anxiety, agitation, and insomnia (Champagne, Mullen, Dickson, &
Krishnamurty, 2015; Douglas-Hall & Whicher, 2015). To manage these symptoms,
patients often are prescribed medications (Carmona-Huerta et al., 2019; Douglas-Hall &
Whicher, 2015; Stroup & Gray, 2018). In the inpatient MH setting, these symptoms can
be exacerbated. Patients will often be prescribed as needed (PRN) medications in
addition to their already scheduled medications to reduce discomfort symptoms while
hospitalized (Douglas-Hall & Whicher, 2015). Patients receiving multiple medications
intended to treat mental illness are at risk for adverse side effects, dependency, drug-drug
interactions, longer hospital length of stay, and future medication non-compliance (Baker
& Aebi, 2017; Bire & Gawade, 2018; Carmona-Huerta et al., 2019). These issues all lead
to potential physical and emotional patient harm and increased healthcare costs (Abraha,
Cruz-Jentoft, Soiza, O’Mahony, & Cherubini, 2015; Carmona-Huerta et al., 2019;
Douglas-Hall & Whicher, 2015). Providing non-pharmacological alternative treatments
to reduce the discomfort of anxiety, agitation, and insomnia among hospitalized MH
patients may lessen the need for PRN medication administration and thus reduce risks
associated with receiving multiple medications.
Sensory based interventions (SBIs), such as deep pressure stimulation (DPS), are
potential non-pharmacological treatments that have been shown to decrease anxiety,
agitation, and insomnia in the inpatient MH setting (Ackerley, Badre, & Olausson, 2015;
Andersen, Kolmos, Andersen, Sippel, & Stenager, 2017; Reynolds, Lane, & Mullen,
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2015; Wiglesworth & Farnworth, 2016). DPS is considered a tactile SBI in which
pressure is used to induce a calming sensation (Losinski, Cook, Hirsch, & Sanders,
2017). A form of DPS that has been implemented in some inpatient MH units is the use
of WBs. WBs provide a promising alternative to safely and effectively reduce the
discomfort of anxiety, agitation, and insomnia in the inpatient MH setting without
patients being given additional medications to treat these symptoms.
The symptoms of anxiety, agitation, and insomnia experienced by hospitalized
MH patients need to be addressed because these symptoms can decrease treatment
efficacy for admitting diagnoses and prolong patient hospitalization (Gee et al., 2019;
Pyrke et al., 2017; Van Veen, Karsten, & Lancel, 2017). Providing non-pharmacological
treatments decreases risks that PRN medications present, while still ensuring these
symptoms are being attended to.
Clinical Question
A literature review was conducted in order to understand the clinical research
available to support this quality improvement project’s PICOT question. This project’s
PICOT question defines (P) population as hospitalized adult MH patients in a MH facility
located in a rural Midwest county, (I) intervention as hospital staff offering WBs first for
anxiety, agitation, and insomnia symptoms, (C) comparison as hospital staff offering
PRN medications first, (O) outcome as quantity of PRN medications administered, and
(T) time as 90 days. The PICOT question is: Among hospitalized adult MH patients in a
MH facility located in a rural Midwest county, how does staff offering WBs first for
anxiety, agitation, and insomnia symptoms compared to staff offering PRN medications
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first impact the quantity of PRN medications administered for these symptoms over a
period of 90 days?
The databases used for this literature review include Cumulative Index of Nursing
and Allied Health Literature (CINAHL), PubMed, PsycArticles, PsychNFO, and
Cochrane Library. Keywords initially utilized were weighted blankets, mental health,
inpatient mental health, non-pharmacological, alternative therapies, anxiety, agitation,
and insomnia. After extensive searching, a limited number of articles were found using
these keywords. The search was widened to include the keywords of sensory room, deep
pressure stimulation, sensory based interventions, and antipsychotic medications.
Boolean operators OR, *, AND were used to enhance the search. Inclusion criteria
included articles in the English language, human subjects, all ages and MH settings, and
articles published within the last five years. Eligible articles were next reviewed for
evidence level and quality. The literature review was limited to articles with an evidence
level of I through V and a quality grading of A or B according to the Johns Hopkins
Nursing Evidence-Based Practice: Level and Quality Guide (Appendix A) (Dearholt &
Dang, 2017). Twenty articles and three clinical practice guidelines that matched the
inclusion criteria were identified. Of these 20 articles included for review, six articles
specifically included WBs as a non-pharmacological treatment in either the MH inpatient
or outpatient setting. Four separate articles discussed the effects of DPS, with
interventions of weighted vests in two of the four articles, a body cushion in one, and
massage in the other. Two additional articles provided evidence for the use of different
SBIs (including WBs) on the treatment of agitation in the MH inpatient setting. Three
other articles provided evidence on non-pharmacological treatment options and

WEIGHTED BLANKETS

4

importance. The final five articles provided evidence on risks of antipsychotic
medications and PRN antipsychotic medication use in the inpatient and outpatient MH
settings. Turning to the three clinical practice guidelines, none addressed WB use, but
were included because of their relation to the importance of finding non-pharmacological
treatment options.
The included articles and clinical practice guidelines were appraised using the
Johns Hopkins Nursing Evidence-Based Practice: Level and Quality Guide(Dearholt &
Dang, 2017) This guide ranks the rigor of the evidence on a scale of I through VII, and
the quality of the evidence with a grade of A, B, or C. Five articles were ranked as a
level I evidence level, five as level II evidence, eight as level III evidence, three as level
IV, and two pilot studies as level V evidence ranking. An organized table of the literature
is found in Appendix B and a breakdown of the rank and grades of the articles is found in
Appendix C.
Evidence Findings
The literature was organized into topics that included: risks of pharmacological
treatments; benefits of non-pharmacological treatments; sensory effects of WBs; and WB
effects on (a) anxiety, (b) agitation, (c) insomnia, and (d) specific MH diagnoses.
Risks of pharmacological treatments. Mental illness that requires
hospitalization is often treated with scheduled psychotropic medications, which are
medications that affect the central nervous system (CNS) with the purpose of treating
mental illness (Carmona-Huerta et al., 2019). Many psychotropic medications have a
narrow therapeutic index, making adverse reactions more likely to occur (Borges,
Vedana, Dias Castilho, & Miasso, 2017).
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A particularly high-risk psychotropic medication family that is used often in the
inpatient MH setting is antipsychotic medications. Antipsychotic medications are divided
into two groups: typical or first-generation antipsychotics and atypical or secondgeneration antipsychotics (Bire & Gawade, 2018; Stroup & Gray, 2018). Antipsychotic
medications are the mainstay treatment for acute psychosis (i.e. delusions, hallucinations)
and agitation occurring in the hospital setting (Baker & Aebi, 2017; Bire & Gawade,
2018; Douglas-Hall & Whicher; Stroup & Gray, 2018). Antipsychotic medications are
also prescribed for schizophrenia, psychotic disorders, bipolar disorder, and severe
depression, along with off-label use for personality disorders, insomnia, and delirium
(Stroup & Gray, 2018). Due to the effectiveness of antipsychotic medications, they are
frequently used in the inpatient MH setting as both scheduled and PRN medications (Bire
& Gawade, 2018).
Side effects are common with antipsychotic medications placing patients at risk
for an adverse health event and non-compliance (Bire & Gawade, 2018). The most
common adverse side effects from these medications that can influence a patient’s
willingness to continue the medication are weight gain, sexual dysfunction, and
anticholinergic effects (dry mouth, constipation). Serious and potentially life-threatening
side effects and drug-drug interactions can also occur. These include extrapyramidal
symptoms (EPS) (parkinsonian, akathisia, dystonia), tardive dyskinesia, neuroleptic
malignant syndrome, serotonin syndrome, metabolic syndrome, Stevens-Johnson
syndrome, myocarditis, orthostatic hypotension, and agranulocytosis (Baker & Aebi,
2017; Limandri, 2020; Stroup & Gray, 2018).
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Even when antipsychotics are effective, PRN medications are often added during
times of acute distress, which frequently occurs in the inpatient setting. Along with
antipsychotics, the most commonly used PRNs in the inpatient MH setting are
benzodiazepines and antihistamines. These three pharmacological families of
medications have sedation side effects, placing patients at risk for injuries due to
cognitive changes. Also, if symptom relief occurs it can be unclear if the scheduled
medications or the PRN medications caused the patient improvement. Even though PRN
medication use is a widely practiced treatment in the inpatient MH setting, quality
research does not exist that shows significant patient benefit with the addition of PRN
medications (Douglas-Hall & Whicher, 2015).
Drug-drug interaction risk is elevated within the inpatient MH population due to
three reasons: the use of different psychotropic medications used together, the use of
psychotropic medications used with non-psychotropic medications (Carmona-Huerta et
al., 2019), and typical and atypical antipsychotic medications given together (DouglasHall & Whicher, 2015). Drug-drug interactions are not only a concern because the patient
is potentially placed in harm due to sedation effects, cognitive changes, and EPS, but also
because the interaction may defer patients from adhering to medication regiments in the
future (Baker & Aebi, 2017; Carmona-Huerta et al., 2019; Eiring et al., 2015; Gartlehner
et al., 2017).
Importance of non-pharmacological treatments. Anxiety, agitation, and
insomnia can lead to patients displaying behaviors that are physically threatening to
themselves, their peers, and staff. When incidents like this occur in the inpatient MH
setting, the use of restraint and/or seclusion is necessary to maintain safety within the
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environment. Even though restraint and/or seclusion is considered a non-pharmacological
intervention, it is always considered as a last resort. In the inpatient MH setting, other
non-pharmacological treatments are being used to prevent harmful patient behaviors and
are being seen as important alternatives to restraint and seclusion (Andersen et al., 2017;
Björkdahl, Perseius, Samuelsson, & Lindberg, 2016; Wiglesworth & Farnworth, 2016).
The American Psychiatric Nurses Association (APNA) (2014) issued a position statement
stating the APNA’s commitment to reduce and ultimately eliminate restraints and
seclusions in the inpatient MH setting. WBs have been shown to calm patients when used
in sensory rooms, or private areas with multiple SBIs available for use, in the inpatient
MH setting (Björkdahl et al., 2016; Wiglesworth & Farnworth, 2016). Preventing
physical escalation through WB use can potentially provide an alternative to restraint and
seclusion, leading to reduction in these practices.
The Texas Medication Algorithm Project, created by MH specialists, is a set of
algorithms that offers pharmacological treatment guidance to providers for patients with
three of the most common mental illnesses (major depressive disorder, schizophrenia,
and bipolar 1 disorder) (Crismon, Argo, Bendele, & Suppes, 2008). These algorithms
recommend mono-pharmacological therapy before polypharmacy for the treatment of
depression (Suehs et al., 2008), schizophrenia (Argo et al., 2008), and bipolar disorder
(Crismon et al., 2008). In addition, the algorithms recommend if additional medications
are needed, especially in the inpatient MH setting when patients’ symptoms are often
increased, tapering off these additional medications is important when the medications
are no longer indicated (Crismon et al., 2008). WBs provide an alternative to the need of
additional medications, along with a treatment to consider when tapering off certain
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medications is indicated. These three clinical practice guidelines are limited because they
only include the diagnoses of depression, schizophrenia, and bipolar disorder.
Sensory effects of weighted blankets. SBIs are used to increase comfort and
self-control when increased intensity of sensory information occurs. This sensory
overload (multiple senses being stimulated simultaneously) can cause patient anxiety,
agitation, and insomnia to become overwhelming (Wiglesworth & Farnworth, 2016).
There are many SBIs with DPS being one of the most common. DPS affects the tactile
sensory system and can be implemented in the form of massage, holding, hugging, and
compression (Bestbier & Williams, 2017). Compression can be created through the use of
weighted coverings, like WBs (Losinski et al., 2017).
WBs produce a sense of calm by creating a sensation of being held or squeezed.
This pressure sensation influences the autonomic nervous system (ANS), which controls
involuntary functions within the body. The ANS is divided into two divisions: the
sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS). The
SNS controls the flight-or-fight response and when activated increases anxiety and
tension. Physical symptoms that occur with SNS activation include increased heart rate,
blood pressure, and respirations. The PNS produces calm by slowing down functions,
such as a lowered heart rate and respirations through increased vagal tone (Champagne et
al., 2015). The DPS that WBs produce provide a reduction in SNS activity and a
stimulation in PNS activity. This creates a decrease in stress symptoms and an increase in
calm sensations (Ackerley et al., 2015; Bestbier & Williams, 2017; Champagne et al.,
2015; Reynolds et al., 2015).
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Current recommendations for the use of WBs can be found for weight selection
and duration of use. WBs have been found to be most effective at a weight of 10% of the
patient’s body weight or higher. Less than 10% has not been shown to be effective in
inducing a calming sensation (Ackerley et al., 2015). Greater than 10% if tolerated by the
patient has been shown to be effective and safe. The WBs should be used for at least 15
minutes for the full ANS effects to occur, with longer being more ideal. A calm
environment with minimal distractions is also recommended for increased effectiveness.
(Champagne et al., 2015).
Weighted blankets reducing anxiety. The Diagnostic and Statistical Manual of
Mental Disorders, 5th edition (DSM-5) defines generalized anxiety disorder (GAD) as
having extreme anxiety and worry that is difficult to control and leads to unwanted
symptoms that affect daily life (e.g., irritability, fatigue, sleep disturbances) most days for
at least six months (American Psychological Association [APA], 2013). Hospitalized
patients may be admitted for GAD or similar anxiety disorders, or they may experience
occasional anxiety while in the hospital setting that interferes with treatment (Champagne
et al., 2015). DPS has been shown to reduce anxiety and improve academic success and
concentration in children with autism, intellectual disabilities, and behavioral disorders
(Bestbier & Williams, 2017; Polak, Hutchinson, Perryman, & Brueck, 2017; Yunus, Liu,
Bisset, & Penkala, 2015). In the adult outpatient MH population, the use of weighted
vests has been shown to decrease anxiety and impulsivity, and increase attention
capabilities (Reynolds et al., 2015). Hospitalized MH adult patients have displayed a
decrease in anxiety during their inpatient stay when WBs were used in a sensory room
setting with other SBIs (Wiglesworth & Farnworth, 2016). WBs used in addition to
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medications may lead to decreased anxiety, as suggested in the pilot study performed by
Champagne et al. (2015).
Weighted blankets reducing agitation. The DSM-5 defines the symptom of
agitation as increased physical activity related to psychological tension that can lead to
aggression (APA, 2013). In the inpatient MH setting, agitation often occurs as a symptom
of other MH disorders (e.g. schizophrenia, mania) and can lead to psychomotor agitation
requiring restraint, seclusion, and/or PRN medications (Andersen et al., 2017).
Recognizing agitation before violence occurs creates a safer environment for patients and
staff (Vieta et al., 2017). A standard protocol for controlling agitation in the inpatient MH
setting currently does not exist. Verbal re-direction, environmental changes, and least
restrictive options are considered first-line treatments before the use of restraints and/or
medications (Garriga et al., 2016; Vieta et al., 2017).
In the inpatient MH setting, sensory rooms are being explored as an effective way
to reduce agitation. Sensory rooms introduce a variety of SBIs (including WBs) in a
secluded area for patients to use when feeling anxious, agitated, and/or aggressive
(Björkdahl et al., 2016; Wiglesworth & Farnworth, 2016). Andersen et al. (2017)
conducted a study showing significant reduction in restraints and forced medications on
an adult inpatient MH unit that used SBIs compared to a MH unit that did not over a 12month period. If implemented prior to physical aggression, SBIs can provide hospitalized
MH patients with strategies to decrease agitation and violent behaviors, which often
otherwise require PRN medications (Andersen et al., 2017; Björkdahl et al., 2016;
Wiglesworth & Farnworth, 2016).
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Weighted blankets reducing insomnia. Insomnia is defined by the DSM-5 as a
discontentment in quality and/or quantity of sleep (APA, 2013). Insomnia often occurs in
the MH hospital setting due to environmental factors and effects from the MH crisis the
patient is experiencing. Insomnia can increase anxiety and agitation, which can delay
effective insomnia treatment in the inpatient MH setting, leading to potentially increased
length of hospitalization (Champagne et al., 2015). If insomnia remains consistent and
continues when discharged, there is a higher risk of symptom relapse (Gee et al., 2019).
Non-pharmacological treatments to decrease insomnia can lead to improved sleep,
reduced depression symptoms, and increased safety, because insomnia medications often
have adverse and dangerous side-effects (Champagne et al., 2015; Gee et al., 2019).
WBs have been shown to induce longer sleep intervals, improve sleep quality, and
reduce the duration needed to fall asleep in non-hospitalized adults with insomnia
(Ackerley et al., 2015). Hospitalized adults may have insomnia reduction with WB use;
however, medications are often used in conjunction with the WB (Champagne et al.,
2015). Within the pediatric population there are conflicting findings on the effectiveness
of WBs on insomnia. France, McLay, Hunter, and France (2018) found that autistic
children did not show any objective signs that WBs provided insomnia relief; however,
parents of the children found comfort in the child using the blanket and did respond
favorably to their use.
Weighted blanket effectiveness on specific MH diagnoses. Anxiety, agitation,
and insomnia are all symptoms of many MH diagnoses, including schizophrenia,
psychotic disorders, and bipolar disorder (APA, 2013). The research did not indicate the
effectiveness of WBs specifically with patients who suffer from these diagnoses;
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however, four articles mentioned these diagnoses being included in data collection on
inpatient units. Three of these articles focused on SBIs leading to decreased agitation
(Andersen et al., 2017; Björkdahl et al., 2016; Wiglesworth & Farnworth, 2016).The
other article included these diagnoses when creating a protocol for psychomotor agitation
in the MH hospital setting and recommended non-invasive treatments offered first (Vieta
et al., 2017).
Severity of mental illness can be increased in certain diagnosis (i.e. schizophrenia,
psychotic disorders, bipolar disorder). Patients with these diagnoses may have an
increased potential for agitation and violence, which at times is due to sensory
dysregulation. SBIs are often avoided for these patients because their use can increase
fear and stress (Wiglesworth & Farnworth, 2016). However, SBIs for treatment of
anxiety, agitation, and insomnia are important because with treatment of sensory
processing dysfunction, symptom reduction can occur. A controlled and monitored
setting, like an inpatient MH unit is considered a safe environment for SBIs, like WBs, to
be used for patients with schizophrenia, psychotic disorders, and bipolar disorder in order
for patients to be introduced to their benefits (Andersen et al., 2017; Björkdahl et al.,
2016; Wiglesworth & Farnworth, 2016).
Gaps in the Literature
Within the literature there are gaps, as identified next. First, most studies on DPS
are performed with children and patients with autism, intellectual disabilities, and sensory
issues, with few focusing on an adult sample or a MH inpatient setting. Second, with all
the various forms of DPS that can be utilized, little research has focused exclusively on
the use of DPS in the form of WBs. The article with the most correlation to the project
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(Champagne et al., 2015) was a pilot study. Third, research of WB impact on PRN
medication use was not found. And fourth, the studies found on reduction of adult
agitation did not use WBs as a single treatment, but with other SBIs.
One systematic review was found looking at effectiveness of PRN medications
when used in the inpatient MH setting. The review concluded that although PRN
medications are widely used, there is a lack of quality supportive research stating that
PRN use in the inpatient MH setting is beneficial. The current practice of PRN
medications being used to manage symptoms in the inpatient setting rely on habit and
clinical experience, rather than evidence (Douglas-Hall & Whicher, 2015).
Currently, in the inpatient MH setting, there are no official clinical guidelines for
the use of WBs or standardized non-pharmacological treatments for the occurrence of
anxiety, agitation, and insomnia. With the (a) potential risks that PRN medications added
to scheduled psychotropic medications pose (Carmona-Huerta et al., 2019) and (b) the
lack of evidence supporting PRN medication use in the inpatient MH setting (DouglasHall & Whicher, 2015), a gap exists in recommended alternatives to reduce the use of
PRN medications given to hospitalized MH patients.
Recommendations for Practice
Mono-pharmacological therapy and least-invasive treatments are recommended as
initial treatments for both hospitalized and non-hospitalized MH patients (Argo et al.,
2008; Crismon et al., 2008; Garriga et al., 2016; Suehs et al., 2008; Vieta et al., 2017).
Finding alternatives for PRN medication use in the inpatient MH setting is recommended
to reduce adverse events that may occur when multiple psychotropic medications are
prescribed (Douglas-Hall & Whicher, 2015; Stroup & Gray, 2018).
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Three articles were identified that researched WB use by inpatient MH adults.
One pilot study used WB as the only treatment and showed reduction in anxiety and
insomnia when used in conjunction with medications (Champagne et al., 2015). The
other two studies used WBs with other SBIs and showed an increase in patient reported
feelings of calmness (Wiglesworth & Farnworth, 2016) and a decrease in agitation and
restraint and seclusion (Andersen et al., 2017).
Based on this initial evidence, the use of WBs as a first-line treatment to reduce
anxiety, agitation, and insomnia in the inpatient setting has the potential to decrease the
quantity of PRN medications needed to control these symptoms. A decrease in PRN
medications given to hospitalized MH patients would decrease drug-drug interactions,
dependency, adverse side effects, increased healthcare costs, and medication noncompliance. The research indicates that inpatient MH facilities would benefit from
practice-based evidence to support their development of institution-based WB policies.
The WB implementation would provide a potential safe and effective way to manage
patient anxiety, agitation, and insomnia without the need for additional medications.
Conclusion
In the MH inpatient setting, patients have increased risk for experiencing anxiety,
agitation, and insomnia that can hinder successful inpatient treatment and prolong
hospitalization. By providing patients with an alternative treatment like WBs, these
symptoms may be reduced without the need for additional medications. WBs can lead to
increased patient safety by reducing potential drug-drug interactions, dependency,
adverse side effects, increased healthcare costs, and reduced medication compliance
caused by PRN medications.
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Appendix A

Johns Hopkins Nursing Evidence-Based Practice: Level and Quality Guide

Evidence Levels
Level I
Experimental study, randomized controlled trial
(RCT)
Systematic review of RCTs, with or without
meta-analysis
Level II
Quasi-experimental study
Systematic review of a combination of RCTs
and quasiexperimental, or quasi-experimental
studies only, with or without meta-analysis
Level III
Non-experimental study
Systematic review of a combination of RCTs,
quasi-experimental and non-experimental
studies, or non-experimental studies only, with
or without meta-analysis
Qualitative study or systematic review with or
without a metasynthesis
Level IV
Opinion of respected authorities and/or
nationally recognized expert
committees/consensus panels based on
scientific evidence
Includes:
• Clinical practice guidelines
• Consensus panels

Quality Guides
A High quality: Consistent, generalizable results; sufficient
sample size for the study design; adequate control; definitive
conclusions; consistent recommendations based on
comprehensive literature review that includes thorough
reference to scientific evidence

B Good quality: Reasonably consistent results; sufficient
sample size for the study design; some control, fairly
definitive conclusions; reasonably consistent
recommendations based on fairly comprehensive literature
review that includes some reference to scientific evidence

C Low quality or major flaws: Little evidence with
inconsistent results; insufficient sample size for the study
design; conclusions cannot be drawn

A High quality: Material officially sponsored by a
professional, public, private organization, or government
agency; documentation of a systematic literature search
strategy; consistent results with sufficient numbers of welldesigned studies; criteria-based evaluation of overall
scientific strength and quality of included studies and
definitive conclusions; national expertise is clearly evident;
developed or revised within the last 5 years

B Good quality: Material officially sponsored by a
professional, public, private organization, or government
agency; reasonably thorough and appropriate systematic
literature search strategy; reasonably consistent results,
sufficient numbers of well-designed studies; evaluation of
strengths and limitations of included studies with fairly
definitive conclusions; national expertise is clearly evident;
developed or revised within the last 5 years

C Low quality or major flaws: Material not sponsored by an
official organization or agency; undefined, poorly defined, or
limited literature search strategy; no evaluation of strengths
and limitations of included studies, insufficient evidence with
inconsistent results, conclusions cannot be drawn; not
revised within the last 5 years
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Level V
Based on experiential and non-research
evidence
Includes:
• Literature reviews
• Quality improvement, program or financial
evaluation
• Case reports
• Opinion of nationally recognized experts(s)
based on experiential evidence
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Organizational Experience:

A High quality: Clear aims and objectives; consistent results
across multiple settings; formal quality improvement,
financial or program evaluation methods used; definitive
conclusions; consistent recommendations with thorough
reference to scientific evidence

B Good quality: Clear aims and objectives; consistent results
in a single setting; formal quality improvement or financial or
program evaluation methods used; reasonably consistent
recommendations with some reference to scientific evidence

C Low quality or major flaws: Unclear or missing aims and
objectives; inconsistent results; poorly defined quality
improvement, financial or program evaluation methods;
recommendations cannot be made
Literature Review, Expert Opinion, Case Report,
Community Standard, Clinician Experience, Consumer
Preference:

A High quality: Expertise is clearly evident; draws definitive
conclusions; provides scientific rationale; thought leader(s)
in the field

B Good quality: Expertise appears to be credible; draws fairly
definitive conclusions; provides logical argument for opinions

C Low quality or major flaws: Expertise is not discernable or
is dubious; conclusions cannot be drawn
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Appendix B
Evidence Table

Topic &
Author(s) &
Date

Study
Design

Participants,
Sample Size, &
Setting

Intervention

Results

Comments:
Strengths/
Weaknesses

Gaps

Recommendations
for Practice

Evidence
Level

Risks of
Pharmacologi
cal
Treatments
Baker, J., &
Aebi, C.
(2017)

Chart
Review

1088 patients
discharged from
a state
psychiatric
hospital in
Oregon that
were continued
on antipsychotic
medications.

The review
looked at
readmission
and mean to
time to
readmission
between
patients
discharged
on injectable
antipsychotic
s,
antipsychotic
polypharmac
y, and
clozapine
compared to
oral
antipsychotic
monotherapy

Patients
discharged
on
injectable
psychotic
monotherapy had
lower
readmission
rates
compared to
patients
discharged
on poly
pharmacy

Strengths:
large sample
size
Weakness:
difficult to
apply to
population

Chart
review only
consisted on
patients at
one facility

Include other MH
facilities and
patients with
different
characteristics

IIIB

Risks of
Pharmacologi
cal
Treatments

A
descript
ive
study

100 patients who
are on
maintenance
treatment and

To assess
awareness &
practice on
side effects of

patients
receiving
maintenance
treatment

Strengths:
sample size
Weakness:
article states

Gaps:
descriptive
study

Antipsychotic
medications have
various side effects,

IIIB
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Topic &
Author(s) &
Date

Study
Design

Participants,
Sample Size, &
Setting

Intervention

Results

Comments:
Strengths/
Weaknesses

Bire, R. S., &
Gawade, E.
(2018)

design
with
cross
sectiona
l survey
approac
h

receiving
Antipsychotic
drugs

antipsychotic
drugs and its
management
among
patients
receiving
maintenance
treatment.

had average
level of
awareness.

that patients
need
medication
education but
did not address
the best way to
educate
patients
effectively.
self-prepared
dichotomous
questionnaires
and checklist
was used for
data
collection.

Risks of
Pharmacologi
cal
Treatments
Borges, T. L.,
Vedana, K. G.
G., Dias
Castilho, E.
C., & Miasso,
A. I. (2017)

Quantitati
ve, crosssectional
and
descriptiv
e
correlatio
nal
study.

430 primary
mental health
patients taking
antipsychotic
medications. 190
had more than two
prescribed
medications
.

Drug-Reax
Thompson
Healthcare
System
program was
used to
question
patients
about drugdrug
interactions
occurring
while on

high
prevalence of
potential
moderate
and severe
drug-drug
interactions
in primary
healthcare
MH patients
taking
antipsychoti
cs

Strengths:
large sample
size,
intervention
tool was
reliable.
Weakness:
relies on
patient selfreport

Gaps

Recommendations
for Practice

Evidence
Level

those patients doing
regular follow up and
are on maintenance
treatment should have
knowledge regarding
side effects of
antipsychotic drugs to
live the
life normally and in
productive way.

Limited to
patients in
the primary
health
setting with
non-severe
mental
illness.

Reducing
polypharmacy is
important to
ensure safety in
medication, since it
would decrease the
chances
of having DDI.

IIIA
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Topic &
Author(s) &
Date

Study
Design

Participants,
Sample Size, &
Setting
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Intervention

Results

Comments:
Strengths/
Weaknesses

Gaps

Recommendations
for Practice

Evidence
Level

The mean
number of
drugs used
during
hospitalizatio
n was 7.8
drugs per
patient. The
mean
prescribed
psych drugs
was 4.07.
81.4%
of patients
were
prescribed 6
or more drugs
and were 5
times more
likely to
suffer a
secondary
effects 14.2%
had

Strengths:
large sample
size
Weakness:
limited to on
population:
inpatient MH
patients in a
Mexican
hospital.

Gaps: Did
not compare
results to
other
populations.
Demographi
cs may have
influenced
results.
Severity of
reactions
was not
reported.

Antipsychotic
polypharmacy is not
recommended, but
often still happens.
Reduction in this
practice may reduce
negative patients
outcomes.

IIIA

antipsychotic
medication.

Risks of
Pharmacologi
cal
Treatments
CarmonaHuerta, J.,
Castiello-de
Obeso, S.,
RamírezPalomino, J.,
DuranGutierrez, R.,
MullerCardona, D.,
Grover-Paez, F.,
… MedinaDavalos, R.
(2019)

longitu
dinal,
retrospe
ctive
study

140 discharged
patients
within three
months in a
psychiatric
hospital in
Mexico

The objective
of the present
study was to
identify the
prevalence of
polypharmacy,
evaluate
adverse effects
associated to
the use of
psych drugs
and to
estimate the
risk in specific
groups.
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Topic &
Author(s) &
Date

Study
Design

Participants,
Sample Size, &
Setting
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Intervention

Results

Comments:
Strengths/
Weaknesses

Gaps

Recommendations
for Practice

Evidence
Level

Strengths:
High level of
research,
searched
many
studies/clinic
al practice
guidelines.
Weakness:
article from
2015, no
other more

limited to
inpatients
with
schizophreni
a or
schizophreni
a like
illness. With
this
extensive
search,
benefits of

PRN regimens, are
widely used; however,
are unevaluated
scientifically, which
should be recognized
when producing
protocols on the
treatment of acute
psychiatric
disturbance.

IA

polypharmacy
while
receiving
antipsychotics
and had more
than twice the
risk of
presenting
extrapyrami
dal
symptoms
for each
added psych
drug,
hospital stay
increased by
6.56 days.
Risks of
Pharmacologi
cal
Treatments
Douglas-Hall,
P., &
Whicher, E.
V. (2015)

System
atic
Review

Searched the
Cochrane
Schizophrenia
Group's Trials
Register and
registries of clinical
trials, in November
2001, March 2006,
July 2012 and
October 2013. Not
been able to identify
any randomized
trials comparing 'as
required' medication

Reviewing all
relevant
randomized
controlled trials
involving
hospital
inpatients with
schizophrenia or
schizophrenialike
illnesses,
comparing any
regimen of
medication

No evidence
from within
randomized
trials was found
to support the
common
practice of asneeded
psychiatric
medications.
Current
practice is
based on
clinical

WEIGHTED BLANKETS
Topic &
Author(s) &
Date

Importance
of NonPharmacologi
cal
Treatments
Gartlehner,
G., Wagner,
G., Matyas,
N., Titscher,
V., Greimel,
J., Lux, L.,…
Lohr, K. N.
(2017)

Study
Design

System
atic
review
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Participants,
Sample Size, &
Setting

Intervention

Results

Comments:
Strengths/
Weaknesses

Gaps

regimens to regular
regimens of the
same
drug.

administered for
the short-term
relief of
behavioral or
psychotic
symptoms,
to be given at
PRN.

experience
and habit
rather than
high quality
evidence.

recent
articles were
round.

PRN
medications
were not
found in
regard to
controlling
behavioral
and
psychotic
features of
patients with
schizophreni
a like
illness.

19 systematic
reviews or metaanalysis of
randomized
controlled trials
(RCTs)

Reviewing
pharmacolog
ical and nonpharmacolog
ical
treatments
for major
depressive
disorder
(MDD).

Second
gene-ration
antidepressa
nts were
supported
with high
strength
evidence,
and a
statistically
significant
higher rate
of
discontinuat
ion because

Strengths
High level of
research
looked at
140
pharmacolog
ical and nonpharmacolog
ical
treatments
for MDD.
Weakness
did not
research
combination

Limited to
patients with
MDD. Did
not directly
research
WBs or
deep
pressure
stimulation.

Recommendations
for Practice

Evidence
Level

For patients who
strongly disagree
with
pharmacological
treatments for
depression, should
be offered
evidence-based
nonpharmacological
treatments that have
been compared with
the effectiveness of
antidepressants for

IA

WEIGHTED BLANKETS
Topic &
Author(s) &
Date

Risks of
Pharmacologi
cal
Treatments
Gee, B.,
Orchard, F.,
Clarke, E.,
Joy, A.,
Carke, T., &
Reynolds, S.
(2019)

Study
Design

Metaanalysis
of
RCTs

Participants,
Sample Size, &
Setting

49 trials were
included. Data
on 5908
participants
were included.
Mostly adults
with only 4
studies including
children under
18 and no one
under 11 was
used.

27
Intervention

Aim of the
review was
to examine
whether nonpharmacolog
ical
interventions
for sleep
were
effective in
reducing
symptoms of
depression.

Results

Comments:
Strengths/
Weaknesses

of adverse
events than
placebo.
Cognitive
behavioral
therapy and
mindfulness
produces
responses to
treatment
similar to
2nd-generation
antidepressa
nts.

of
pharmacolog
ical and nonpharmacolog
ical
interventions
.

Nonpharmacolo
gical sleep
intervention
s are
effective in
reducing
severity of
depression.

Strengths
only RCTs,
rigorous
search
criteria
Weakness
many studies
excluded
people who
reported
elevated
depression
symptoms
and history

Gaps

Recommendations
for Practice

Evidence
Level

the treatment of
MDD.

The nonpharmacolo
gical
measures
are not
listed in
detail.
Limited to
reduction of
depression
symptoms.

Nonpharmacological
sleep interventions
could be offered as
treatment for
depression, which
could improve
patient access to
treatment due to the
low cost of nonpharmacological
options.

IB

WEIGHTED BLANKETS
Topic &
Author(s) &
Date

Study
Design

Participants,
Sample Size, &
Setting

28
Intervention

Results

Comments:
Strengths/
Weaknesses

Gaps

Recommendations
for Practice

Evidence
Level

of major
depression.

Importance
of NonPharmacologi
cal
Treatments
Björkdahl, A.,
Perseius, K. I.,
Samuelsson,
M., & Lindberg,
M. H. (2016)

Crosssectiona
l
descript
ive
survey
design

126 staff members
who worked
with inpatient
psychiatric
patients using a
sensory room
located in a
Swedish
inpatient
psychiatry
setting

Sensory
room (WBs
included as
an SBI in
these rooms)

Staff
endorsed
that after
using the
sensory
rooms, the
patients
were
empowered
and had an
increase in
emotional
self-care
and
wellbeing

Strengths
included
inpatient
mental
health
patients,
adequate
number for
sample size
Weakness
Qualitative
study, 95%
of responses
from nurses,
difficult to
generalize
this
information.

Limited to
inpatient
mental
health
setting, did
not explore
how patients
felt about
the sensory
rooms, staff
perception
was
measured,
which may
be bias.

Patient-centered
care can be
delivered by nurses
through the use of a
sensory room. Staff
finds sensory rooms
helpful in the
inpatient unit and
more research
should be done to
safely implement
them.

IIIB

Importance
of NonPharmacologi
cal
Treatments

Clinical
Practice
Guideli
ne

Group of mental
health experts
creating a
practice
guideline for the

Extensive
study of
successful
treatment
options and
patient safety

Algorithm
created by
panel of
MH experts
after
extensive

Strengths
well
respected
algorithm,
created by
experts

Limited to
diagnosis of
schizophreni
a

Monopharmacological
therapy is
recommended.

IVA

WEIGHTED BLANKETS
Topic &
Author(s) &
Date

Study
Design

Argo, Crismon,
Miller, Moore,
Bendele, &
Suehs.
(2008)
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Participants,
Sample Size, &
Setting

Intervention

Results

Comments:
Strengths/
Weaknesses

treatment of
schizophrenia.

for the
treatment of
schizophreni
a

research that
provides a
practice
guideline on
how to treat
schizophren
ia

Weakness
not gold
standard,
provider
preference if
algorithm is
used or not

Gaps

Recommendations
for Practice

Evidence
Level

Importance
of NonPharmacologi
cal
Treatments
Crismon,
Argo,
Bendele, &
Suppes.
(2008)

Clinical
Practice
Guideli
ne

Group of mental
health experts
creating a practice
guideline for the
treatment of
bipolar disorder.

Extensive
study of
successful
treatment
options and
patient safety
for the
treatment of
bipolar
disorder.

Algorithm
created by
panel of
mental
health
experts after
extensive
research that
provides a
practice
guideline on
how to treat
bipolar
disorder.

Strengths
well
respected
and used
algorithm,
created by
experts
Weakness
not
considered
gold
standard,
provider
preference if
algorithm is
used or not

Limited to
diagnosis of
bipolar
disorder.

Non-invasive and
nonpharmacological
options should be
tried first (in the
absence of
psychotic features).
If medication is
needed, monopharmacological
therapy is
recommended.

IVA

Importance
of NonPharmacologi
cal
Treatments

System
atic
review

16 quantitative
data studies
included after
reviewing 11,215
citations.

Find the
preference
that adults
with mental
disorders

Side effects
and
symptom
information
was more

Strength
Reviewed
with
Preferred
Reporting

The mental
disorders
were limited
to
schizophreni

Preference studies
are often
widespread with
insufficient
reporting- creating a

IIB

WEIGHTED BLANKETS
Topic &
Author(s) &
Date
Eiring, O.,
Landmark, B.
F., Aas, E.,
Salkeld, G.,
Nylenna, M.,
& Nytroen, K.
(2015)

Study
Design

Participants,
Sample Size, &
Setting
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Intervention

Results

Comments:
Strengths/
Weaknesses

Gaps

Recommendations
for Practice

place on
medication
treatment
options, so
providers are
aware of
what sideeffects need
to be
discussed
when
introducing
medication
options.

important to
patients
compared to
functioning
and course
of illness
process
when
providers
discussed
treatment
options.
Severe
disease and
hospitalizati
on were
least
desirable.
Perceived
side effects
effected
patients
negatively.

Items for
Systematic
Reviews and
MetaAnalyses
(PRISMA)
guidelines.
Able to
generalize
results.
Weakness
Studies were
often small
number of
participants
with similar
diagnosis
and studies
with low
statistically
significant
differences
were
included.

a,
depression,
bipolar
disorder,
and
attention
deficient
hyper-active
disorder.

more concise
reporting method
that has detailed
study design and
outcome
descriptions that are
being told to
patients can create
more accurate
results.

Evidence
Level
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Topic &
Author(s) &
Date

Study
Design

Participants,
Sample Size, &
Setting

Intervention

Results

Comments:
Strengths/
Weaknesses

Gaps

Recommendations
for Practice

Evidence
Level

Importance
of NonPharmacologi
cal
Treatments
Suehs, Argo,
Bendele,
Crismon,
Trivedi, &
Kurian.
(2008)

Clinical
Practice
Guideli
ne

Group of mental
health experts
creating a practice
guideline for the
treatment of major
depressive
disorder.

Extensive
study of
successful
treatment
options and
patient safety
for the
treatment of
major
depressive
disorder

Algorithm
created by
panel of
mental
health
experts after
extensive
research that
provides a
practice
guideline on
how to treat
major
depressive
disorder.

Strengths
well
respected
and used
algorithm,
created by
experts
Weakness
not
considered
gold
standard,
provider
preference if
algorithm is
used or not

Limited to
diagnosis of
major
depressive
disorder

Non-invasive and
nonpharmacological
options should be
tried first (in the
absence of
psychotic features).
If medication is
needed, monopharmacological
therapy is
recommended.

IVA

WBs effects on
Anxiety
Bestbeir, L.,
& Williams,
T. I. (2017)

Qualitat
ive
study

13 students with
autism spectrum
disorder (ASD)
and severe
intellectual
disabilities (IDs)
located at a
residential school.

Deep
pressure
stimulation
through
brushing,
massage, and
squeezing.
Session were
between 5-15
minutes
delivered
three
times/day for

Six students
showed
significance
improvemen
t in
calmness,
engagement,
responsiven
ess,
happiness,
and
communicat
ion.

Strength
statistical
significance
was found
Weakness
small sample
size,
heterogeneit
y of response

Limited to
ASD youths

Deep pressure gives
benefits to ASD and
severe ID

IIIB

WEIGHTED BLANKETS
Topic &
Author(s) &
Date

Study
Design

Participants,
Sample Size, &
Setting
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Intervention

Results

Comments:
Strengths/
Weaknesses

Gaps

Recommendations
for Practice

Evidence
Level

100% safe
(monitored
by blood
pressure,
pulse, and
pulse
oximetry)
and 60%
effective for
anxiety
reduction
(monitored
by skin
conductance
, EDA, and
self-rating
questionnair
es.

Strengths
objective and
subjective
data used.
Controlled
setting.
Weakness
pilot study,
heterogeneou
s sample

Diagnostical
ly
heterogeneo
us adult
sample,
allowed to
use
medications
for
symptoms
as well

WB can lower
anxiety and are safe
to use in the
inpatient setting.
Further studies need
to happen to better
understand the
neurophysiological
responses.

VA

three months
while in
school.

WBs effects on
Anxiety
and Insomnia
Champagne,
T., Mullen, B.,
Dickson, D.,
Krishnamurty,
S. (2015)

Explora
tory,
pilot
study

30 male and
female inpatient
mental health
patients ages 1864

30-pound
WB

WEIGHTED BLANKETS
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Topic &
Author(s) &
Date

Study
Design

Participants,
Sample Size, &
Setting

Intervention

Results

Comments:
Strengths/
Weaknesses

WBs effects on
Anxiety
Reynolds, S.,
Lane, S. J., &
Mullen, B.
(2015)

Crosssectiona
l

Convenience
sample of 50
adults ages 1840. Pregnant
participants,
cognitive or
intellectual
impairment, or
had a motor
impairment that
would prevent
them from
applying the vest
were not
included. ¼ of
the sample were
being treated for
a psychological
condition.

Vayu Vest, a
wearable,
noninvasive
vest that has
a hand pump
that can
inflate the
vest to
desirable
deep
pressure
levels, was
applied to
participants
as they
played a
brainteaser
game with
increasingly
difficult
tasks to
complete or
questions to
answer.

Wearing
the vest for
even short
periods of
time (3
minutes)
reduced
stress and
increased
calm. Heart
rate,
respiration
rate, and
skin
conduction
were
measured.

Strengths
large sample
size,
quantitative
data was
measured.
Weakness no
control
group, use of
nonstandardized
performance
measure

Gaps

Not
completed
in the
inpatient
setting

Recommendations
for Practice

Evidence
Level

Deep pressure may
be used for reducing
adverse behaviors,
increase attention to
task, reduce
impulsivity.

IIIA
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Topic &
Author(s) &
Date

Study
Design

Participants,
Sample Size, &
Setting

Intervention

Results

Comments:
Strengths/
Weaknesses

Gaps

Recommendations
for Practice

Evidence
Level

WBs effects on
Anxiety
Yunus, Liu,
Bisset, &
Penkala.
(2015)

System
atic
Review

132 studies were
reviewed, 14
were analyzed.
Inclusion criteria
included
subjects ages 219 with
behavioral.

SBIs to
reduce
behaviors.
What
behaviors

Message
therapy
showed the
most
reduction in
behaviors.
Four articles
studied
weighted
vests with
two
showing
increase in
attention
capabilities
and
reduction in
selfstimulation
patterns.

Strengths
Articles
analyzed
with
PRIMSA
chart. Only
articles with
an evidence
level of III or
higher were
used.
Weakness
some small
sample sizes,
cannot
generalize
results.

SBIs were
not clear.
Reduction in
negative
behaviors
not
consistent in
the findings.

SBI has the
potential to be an
affective
intervention within
children to reduce
negative behaviors.
More quality
research is needed.

IIB

WBs Effects on
Agitation
Andersen, C.,
Kolmos, A.,
Andersen, K.,
Sippel, V., &
Stenager, E.
(2017)

Case
Control
Study

Study was over
a 12-month
period on two
inpatient
psychiatric units
each with 17
beds. Men and
women ages 1865 were

Sensorybased
interventions
(SBIs)
including
ball blankets
(same as
WBs), a ball
chair, large

The number
of belt
restraints
and forced
medication
were
significantly
reduced by
42% in the

Strengths
long study
period, has
control
group,
results
showed
significance
Weakness

Does not
include
elderly.
Conducted
on inpatient
unit

SBIs reduced
restraint and forced
medications in the
psychiatric inpatient
unit.

IB

WEIGHTED BLANKETS
Topic &
Author(s) &
Date

WBs Effects on
Agitation
Polak, R.,
Hutchinson,
D., Perryman,
L, & Brueck,
S. (2017)

Study
Design

Nonexperim
ental
study,
pilot
study
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Participants,
Sample Size, &
Setting

Intervention

Results

Comments:
Strengths/
Weaknesses

included. 5371
bed days for the
project setting
and 4627 bed
days for the
control setting.

therapy ball,
therapeutic
music, and
Nintendo
Wii sports
games.

project unit
compared to
the control
unit

limited to
two units.

Nine students
ages 15-22
attending a
residential
treatment
facility which
they attend as
day students. All
participates had
a learning
disability, social
disinhibition,
five with sexual
disinhibition,
and six with
self-injurious
behaviors.
Mental illness
was present in
the participants

Two 15minute
sessions/
week using a
calming
cushion for
12 weeks. A
calming
cushion is a
body length
cushion
made of
nylon, with
polystyrene
filling. A
vacuum
pump
removes the
cushion’s air,
which causes

Statistically
significant
difference in
reported
agitation
and anxiety
pre and post
test results.
Two
students had
dramatic
reductions
in seclusion
or restraint.
One having
nine
restraints in
the month
prior to the
study and

Strengths:
very small pvalue that
showed a
significant
difference in
anxiety and
agitation
levels.
Reduction in
restraint or
seclusion for
two students.
Weakness
very small
sample size,
no validated
instruments
of selfreported

Gaps

Recommendations
for Practice

Evidence
Level

Limited to
youths in a
residential
day program
setting,
limited
studies
involving
adults.

Using a validated
instrument for
measuring anxiety
and agitation, larger
sample size, a
control group,
including persons
with substance
abuse, rape victims,
veterans
traumatized by war.

VA
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Author(s) &
Date

WBs Effects on
Agitation
Vieta, E.,
Garriga, M.,
Cardete, L,
Bernado, M.,
Lombrana,
M., Blanch, J.
… MartinezAran, A.
(2017)

Study
Design

System
atic
Review

36

Participants,
Sample Size, &
Setting

Intervention

Results

Comments:
Strengths/
Weaknesses

including
diagnoses of
posttraumatic
stress disorder,
mood disorder,
autism spectrum
condition,
anxiety, and
schizophrenia.

the cushion
to form
around the
student’s
body shape
causing the
cushion to
act as a
“squeeze
machine”
and gives a
sensation of
being held or
hugged.

only one
post study.
Student two
had 27
seclusion
incidences
pre study
and only 12
post study.

anxiety and
agitation,
scheduled
cushion
session
rather than
when
distress was
occurring.

A systematic
review of the
literature to
develop a
protocol for
early
identification
and clinical
management for
adult patients
with a primary
psychiatric
condition
displaying

Systematic
review of
evidence,
consensus
among
international
experts on
the topic of
PMA using
Delphi
methodology
, consulting
of expert
committee
(eight

Developme
nt of
protocol that
provides
guidance on
selection of
use of
pharmacolo
gical agents,
seclusion,
and physical
restraint for
psychiatric
patients
with PMA.

Strengths
Development
process
included
systematic
review of
evidence
using
Jadad’s and
PRISMA
criteria. A
formal
consensus
method for
the

Gaps

Recommendations
for Practice

Evidence
Level

Presently no
gold
standard for
guideline
guaranteein
g
implementa
ble and
clinically
relevant
recommend
ation.
Protocol
would only
benefit the

Systematic review
of PMA protocols
and assessment of
application can
ensure protocol is
being used and
benefitting patient
and staff.
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Author(s) &
Date

WBs Effects on
Agitation
Garriga,
Pacchiarotti,
Ksper, Zeller,
Allen,
Va´zquez,…
Vieta. (2016)

Study
Design

System
atic
Review

37

Participants,
Sample Size, &
Setting

Intervention

Results

Comments:
Strengths/
Weaknesses

Gaps

psychomotor
agitation (PMA)

psychiatrists,
two nurses,
and one
psychologist)
.

Having a
planned
protocol can
reduce the
burden of
PMA for the
patient and
facility.

agreement
among
experts was
used.
Weakness
clinical
practice
guideline

agitated
patient when
used.

2175 articles
were assessed
and 124 articles
were included
that looked
agitation in the
inpatient mental
health setting
and effective
treatments for
agitation.

Group of
assigned MH
experts
performed an
extensive
literature
search using
the Delphi
method.

22
recommend
ations were
found.
Experts
agreed in
considering
verbal deescalation
and
environment
al
modificatio
n techniques
as first
choice,
considering
physical
restraint as a
last resort.

Strengths:
extensive
research
looking at
high quality
studies,
expert panel
grading the
research,
many
recommenda
tions found
that can be
generalized.
Weakness no
clinical
guidelines
were created

Limited to
inpatient
psychiatric
and
emergency
room setting

Recommendations
for Practice

Evidence
Level

Understand and use
the 22
recommendations to
assess agitation in
the inpatient unit
and use the
recommendations to
guide treatmentstarting with least
invasive, nonmedication or
restraint options
first.
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Date
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Agitation
Wiglesworth,
S., &
Farnworth, L.
(2016).

38

Study
Design

Participants,
Sample Size, &
Setting

Intervention

Mixed
Method
approac
h using
quantita
tive and
qualitati
ve data

Two groups:
female
forensic patients
who used the
sensory room and
the healthcare
staff who
promotes use. The
8 patients were
ages 18-60 on an
inpatient forensic
mental health unit
Common
diagnoses
where
schizophrenia and
other psychotic
disorders,
depression,
personality
disorders, bipolar
disorder, alcohol
or drug
abuse/dependenc
e and intellectual
disabilities. 50
sessions were
recorded.

Sensory
rooms with
WBs
included in
the room.

Results

Comments:
Strengths/
Weaknesses

Gaps

Recommendations
for Practice

Evidence
Level

Patients had
reduced
stress after
sensory
room use.

Strengths:
mixed
approach to
collect data.
Study took
place on an
inpatient MH
unit.
Weakness
did not use
validated
measurement
tool, only
included
females,
limited
participants.

Limited to
inpatient
unit, does
not include
specific use
of WB in
the sensory
room.

Continued research
with a randomized
controlled trial
comparing sensory
room impact with
other activities.
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Author(s) &
Date
WBs Effects on
Insomnia
Ackerley, R.,
Badre, G.,
Olausson H.
(2015)

39

Study
Design

Participants,
Sample Size, &
Setting

Intervention

Repeate
dmeasur
es study
with
pre and
posttest
baseline

33 healthy
participants
complaining of
chronic
insomnia ages
20-66 (11 men,
20 women).
Study took place
in participants
own homes.
Yearlong study.
Each participant
would
participate for 4
weeks.

Weighted
blankets
(WBs).

Results

Comments:
Strengths/
Weaknesses

Gaps

Participants
had longer
sleep time,
decrease in
movements
while using
blankets,
and
subjectively
liked
sleeping
with the
blanket and
found it
easier to
settle down,
had
improved
sleep, and
felt
refreshed in
the
morning.
Both
objective
and
subjective
measures
were
reported.

Strengths
used both
objective and
subjective
methods to
study sleep
patterns.
Weakness no
control
group, short
duration of
study,
inability to
provide
placebo WB

Limited to
patients with
insomnia
diagnosis.

Recommendations
for Practice

Evidence
Level

WBs are a nonpharmacological
intervention that
can be added to
other tools to
improve sleep
quality.
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Author(s) &
Date
WBs Effects on
Insomnia
France, K. G.,
McLay, L. K.,
Hunter, J. E.,
France, M. L.
S. (2018)

40

Study
Design

Participants,
Sample Size, &
Setting

Intervention

Results

Comments:
Strengths/
Weaknesses

Gaps

System
atic
review

Included 79
studies

Aromatherap
y, ketogenic
diets,
elimination
of cow’s
milk,
avoidance of
caffeine,
music, white
noise, bright
light therapy,
deep
pressure
massage,
WB to
enhance
sleep in
children.

Studies
regarding
WBs
showed no
effects on
objective
measures,
but positive
ratings from
family
members.

Strengths
Many studies
included
Weakness
limited
studies on
WBs,
findings
limited to
children

Limited WB
studies.
Limited to
child
population.

Recommendations
for Practice

Evidence
Level

More rigorous
research is needed
to develop
generalized
findings.
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Appendix C
Rank and Grades of Articles

Level of
Evidence

Grade

Number of
Articles

I

A

3

B

2

A

1

B

4

A

3

B

5

IV

A

3

V

A

2

II

III
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Abstract
Introduction: As-needed (PRN) medications are often used as first-line treatment
for mental health (MH) patients experiencing anxiety, agitation, and insomnia
while hospitalized. PRN medications can cause drug-drug interactions,
dependency, adverse side effects, increased healthcare costs and reduced
medication compliance. Weighted Blankets (WBs) are a non-pharmacological
treatment that can be used to reduce anxiety, agitation, and insomnia in the
inpatient MH setting.
Methods: This quality improvement project measured the impact of WBs used as
first-line treatment for anxiety, agitation, and insomnia on the quantity of PRN
medications administered for these symptoms in an inpatient MH setting. WB
education was given to patients and staff offered WBs before PRN medications. A
chart audit was completed comparing PRN medication use in the comparison
group (WB not offered first) versus the intervention group (WB offered first).
Conclusions: The use of WBs as first-line treatment for anxiety, agitation, and
insomnia did not show a clinically significant impact on quantity of PRN
medication used for these symptoms.
Recommendations for Practice: Further research is needed with a longer timeframe and larger sample number to understand potential impact WBs have on
PRN medications use in the inpatient MH setting.
Keywords: weighted blanket, inpatient mental health, anxiety, agitation, insomnia
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Weighted Blankets: Impact on PRN Medication Use in the Inpatient Mental Health Setting
Mental health (MH) patients experience symptoms that cause discomfort,
including anxiety, agitation, and insomnia (Champagne, Mullen, Dickson, &
Krishnamurty, 2015; Douglas-Hall & Whicher, 2015). To manage these symptoms
patients often are prescribed medications (Carmona-Huerta et al., 2019; Douglas-Hall &
Whicher, 2015; Stroup & Gray, 2018). In the inpatient MH setting these symptoms can
be exacerbated. Patients will often be prescribed as needed (PRN) medications in
addition to their already scheduled medications to reduce discomfort symptoms while
hospitalized (Douglas-Hall & Whicher, 2015).
Sensory based interventions (SBIs), such as deep pressure stimulation (DPS), are
potential non-pharmacological treatments that have been shown to decrease anxiety,
agitation, and insomnia in the inpatient MH setting (Ackerley, Badre, & Olausson, 2015;
Andersen, Kolmos, Andersen, Sippel, & Stenager, 2017; Reynolds, Lane, & Mullen,
2015; Wiglesworth & Farnworth, 2016). DPS is considered a tactile SBI in which
pressure is used to induce a calming sensation (Losinski, Cook, Hirsch, & Sanders,
2017). A form of DPS that has been implemented in inpatient MH units is the use of
weighted blankets (WBs).WBs provide a promising alternative to safely and effectively
reduce symptoms of anxiety, agitation, and insomnia in the inpatient setting without
patients being given additional medications.
Background
Significance of Problem
Patients receiving multiple medications intended to treat mental illness are at risk
for adverse side effects, dependency, drug-drug interactions, longer hospital length of
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stay, and future risk of medication non-compliance (Baker & Aebi, 2017; Bire &
Gawade, 2018; Carmona-Huerta et al., 2019; Eiring et al., 2015). These issues all lead to
potential physical and emotional patient harm and increased healthcare costs (Abraha,
Cruz-Jentoft, Soiza, O’Mahony, & Cherubini, 2015; Carmona-Huerta et al., 2019;
Douglas-Hall & Whicher, 2015). The physical and emotional harm is often due to the
types of medications used in the inpatient MH setting. Psychotropic medications,
particularly antipsychotic medications, are medications that although are very effective in
treating mental illness, have low therapeutic indexes, making potential adverse reactions
more likely to occur (Borges, Vedana, Dias Castilho, & Miasso, 2017; Carmona-Huerta
et al., 2019; Douglas-Hall & Whicher, 2015). Antipsychotic medications are commonly
used as PRN medication options for controlling symptoms of anxiety, agitation, and
insomnia in the inpatient MH setting. Cognitive changes, over-sedation, and involuntary
muscle movement and stiffness can occur with the use of these medications and increase
potential harm to be experienced by patients (Douglas-Hall & Whicher, 2015).
The symptoms of anxiety, agitation, and insomnia experienced by hospitalized
MH patients need to be addressed because these symptoms can decrease treatment
efficacy for admitting diagnoses and prolong patient hospitalization (Gee et al., 2019;
Van Veen, Karsten, & Lancel, 2017). Providing non-pharmacological treatments
decreases risks that PRN medications present, while still ensuring these symptoms are
being attended to.
PICOT Question
This project’s PICOT question defines population (P) as hospitalized adult MH
patients in a MH facility located in a rural Midwest county, (I) intervention as hospital
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staff offering WBs first for anxiety, agitation, and insomnia symptoms, (C) comparison
as hospital staff offering PRN medications first, (O) outcome as quantity of PRN
medications administered, and (T) time as 90 days. The PICOT question is: Among
hospitalized adult MH patients in a MH facility located in a rural Midwest county, how
does staff offering WBs first for anxiety, agitation, and insomnia symptoms compared to
staff offering PRN medications first impact the quantity of PRN medications
administered for these symptoms over a period of 90 days?
Evidence Findings
Risks of pharmacological treatments. Mental illness that requires
hospitalization is often treated with scheduled psychotropic medications, which are
medications that affect the central nervous system (CNS) with the purpose of treating a
mental illness (Carmona-Huerta et al., 2019). A particularly high-risk psychotropic
medication family that are often used in the inpatient MH setting are antipsychotic
medications. Patient safety can be jeopardized when PRN medication use is added,
especially if scheduled antipsychotic medications are also being taken. Adverse sideeffects and drug-drug interactions are not only a concern because the patient is potentially
placed in harm, but also because the interaction may defer patients from adhering to
medication regiments in the future (Baker & Aebi, 2017; Carmona-Huerta et al., 2019).
Importance of non-pharmacological treatment options. Anxiety, agitation, and
insomnia can lead to patients displaying behaviors that are physically threatening to
themselves, their peers, and staff. When incidents like this occur in the inpatient MH
setting, the use of restraint and/or seclusion is necessary to maintain safety within the
environment. Even though restraint and/or seclusion is considered a non-pharmacological
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intervention, it is always considered as a last resort. In the inpatient MH setting, other
non-pharmacological treatments are being used to prevent harmful patient behaviors and
are being seen as important alternatives to restraint (Andersen et al., 2017; Björkdahl,
Perseius, Samuelsson, & Lindberg, 2016; Wiglesworth & Farnworth, 2016).
Sensory effects of WBs on Anxiety, Agitation, and Insomnia. SBIs are used to
increase comfort and self-control when increased intensity of sensory information occurs.
This sensory overload (multiple senses being stimulated simultaneously) can cause
patient anxiety, agitation, and insomnia to become overwhelming (Wiglesworth &
Farnworth, 2016). There are many SBIs with DPS being one of the most common. DPS
affects the tactile sensory system and can be implemented in the form of massage,
holding, hugging, and compression (Bestbier & Williams, 2017). Compression can be
created through the use of weighted coverings, like WBs (Losinski et al., 2017).
Gaps in the Literature
Within the literature there are gaps, as identified next. First, most studies on DPS
are performed with children and patients with autism, intellectual disabilities, and sensory
issues, with few focusing on an adult sample or a MH inpatient setting. Second, with all
the various forms of DPS that can be utilized, little research has focused exclusively on
the use of DPS in the form of WBs. The article found with the most correlation to the
project (Champagne et al., 2015) was a pilot study. Third, research of WB impact on
PRN medication use was not found. And fourth, the studies found on reduction of adult
agitation did not use WBs as a single treatment, but with other SBIs.
Currently, in the inpatient MH setting, there are no official clinical guidelines for
the use of WBs or standardized non-pharmacological treatments for the occurrence of
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anxiety, agitation, and insomnia. With the (a) potential risks that PRN medications added
to scheduled psychotropic medications pose (Carmona-Huerta et al., 2019) and (b) the
lack of evidence supporting PRN medication use in the inpatient MH setting (DouglasHall & Whicher, 2015), a gap exists in recommended alternatives to reduce the use of
PRN medications given to hospitalized MH patients.
Recommendations for Practice
Based on the initial evidence found in the literature (see Review of Literature), the
use of WBs as a first-line treatment to reduce anxiety, agitation, and insomnia in the
inpatient setting has the potential to decrease the quantity of PRN medications needed to
control these symptoms. A decrease in PRN medications given to hospitalized MH
patients would help decrease drug-drug interactions, dependency, adverse side effects,
increased healthcare costs and medication non-compliance. The research indicates that
inpatient MH facilities would benefit from practice-based evidence to support their
development of institution-based WB policies. This WB policy implementation could
provide a potential safe and effective way to manage patient anxiety, agitation, and
insomnia without the need for additional medications.
Methods
This project was guided by three theories. The Johns Hopkins Nursing Evidence
Based Practice Model (Dearholt & Dang, 2017) was used to direct the evidence research
process (see Appendices A and B). Margaret Newman’s Theory of Health as Expanding
Consciousness (Newman, 1994) was utilized in creating and delivering the staff and
patient education sessions. Everette Roger’s Diffusion of Innovations Theory (Rogers,
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2003) was the change theory that guided the staff and patients as they adjusted to using
WBs as first-line treatment for anxiety, agitation, and insomnia.
Setting
Implementation of this project occurred in a locked 15-bed inpatient MH facility.
The facility is located within a 64-bed hospital in a rural Midwest county. The unit serves
not only the local community, but the entire state when placement closer to the patient’s
local area is unavailable. The unit serves as a MH crisis treatment center with high patient
turnover; the average length of stay ranges from two to five days. The majority of
discharges are back to the patient’s home with outpatient services in place (D. Brodersen,
personal communication, July 19, 2019).
Before initiation of the intervention, usual treatment of anxiety, agitation, and
insomnia included PRN medications, six group therapy sessions per day, daily patient
rounds with a provider, and one-on-one sessions with direct care staff. Within these
options, PRN medications were the most frequently offered by staff and requested by
patients for the treatment for these symptoms. At the time of the project’s intervention,
there were 19 direct patient care staff members on the unit consisting of 13 registered
nurses (RNs), one licensed practical nurse (LPN), two group therapy technicians, one
discharge coordinator, one social worker, and one substance abuse counselor.
The project setting invested in 25 WBs in June 2019. This created the ability for
patients to be offered WBs for symptoms 24 hours/day. Prior to this investment the
facility had only two WBs. A problem being noticed after the June purchase was that
staff were not consistently offering the WBs to patients for symptoms other than
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insomnia. When the WBs were being offered for insomnia, a PRN medication was often
given first or in conjunction with the blanket use.
Sample
The sample consisted of involuntary and voluntary male and female adult (18 and
older) patients admitted to an inpatient MH facility during two different 90 day periods.
The comparison group was patients admitted prior to the facility’s purchase of 25 WBs
and the intervention group was patients admitted after this WB purchase. The comparison
group included 124 patients (55 males and 69 females) with the average age being 36.4
years old (SD = 15.74; range of 18-65 years). The intervention group included 92 patients
(40 males and 52 females) with the average age being 38.4 years old (SD = 15.10; range
of 18-83 years). The sample is further described in Tables 1, 2, and 3 according to
gender, MH diagnosis, and age distribution.
MH diagnosis was determined by the primary diagnosis listed in the discharge
summary created by the provider. (Patients with severe intellectual disabilities, dementia,
and autism were not included, as these diagnoses are not admitted to the project setting).
Race was not measured through the facility’s EMR, so it was not included in this project.
The average length of stay for both the comparison group and intervention group was the
same: 5.8 days (comparison group: SD = 4.44; range of 1-32 days and intervention
group: SD = 5.47; range of 1-29 days). There were no significant differences between the
comparison and intervention groups on gender, MH diagnosis, age, and length of stay.
All patients when admitted had PRN medication orders. Appendix C lists the
PRN medication options used during both the comparison and intervention time periods.
Intervention Tool
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The evidence-based intervention used was DPS through the use of WBs as firstline therapy for anxiety, agitation, and insomnia. The pressure sensation that WBs create
decreases sympathetic nervous system (SNS) activity and increases parasympathetic
nervous system (PNS) activity. This produces a decrease in stress symptoms and an
increase in calming sensations (Ackerley et al., 2015; Bestbier & Williams, 2017;
Champagne et al., 2015).
At the project setting, 27 WBs were available in 5 different weights (5, 10, 15, 20,
and 25 pounds). The blankets were weighted evenly throughout and made of cotton
material. Patients were able to keep the same blanket for use in their room during their
hospitalization, and blankets were washed and sanitized after patient use.
Procedure
In order for the WBs to be offered first by staff and requested first by patients,
education regarding this change was important. Three educational approaches were used
to provide information regarding the benefits and indications of WBs. First, a face-to-face
staff educational session conducted by the DNP Project Coordinator (Appendix D) was
provided to the staff on the unit. A Know, Want to Know, and Learned (KWL) chart was
used to guide learning. KWL charts have been shown to facilitate learning by reducing
stress and increasing retention of material (Bailey, 2017). Kinesthetic (hands-on) learning
was also provided to the staff through opportunities to use the WBs and describe how the
deep pressure made them feel. Sessions were 20 minutes in length, provided on two
different days, and offered three times/day to provide the staff with multiple opportunities
to attend. Fourteen of the 19 direct patient care staff members attended one of the
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provided educational sessions. Weekly emails from the DNP Project Coordinator
encouraging compliance were sent to staff and stakeholder (see Appendix E).
For the second educational approach, informative and visually appealing signage
(Appendix F) was hung in central patient areas throughout the unit to encourage WB use.
In addition, educational brochures (Appendix G) were provided to all patients in a
welcome folder that was received at admission. Face validity of the educational materials
was determined collectively by the following ten professionals: an inpatient MH clinical
director, a psychiatrist, two psychiatric MH NPs, two MH RNs, a MH group therapy
technician, two certified MH counselors, and one RN clinical educator. The facility’s
marketing director also approved the materials to be used within the facility and a SDSU
librarian approved the material’s reference accuracy. The facility funded costs associated
with printing the posters and brochures.
The third educational approach involved patient education given by the nurses
and/or group therapy technicians. A session regarding WB information was added to the
group therapy schedule and offered three times/week. Appendix H and Appendix I
outlines the two group therapy sessions that were used. Session 1 involved completing a
KWL chart as a group. Session 2 utilized a kinesthetic approach. Both educational
sessions were first taught to patients by the DNP Project Coordinator with the group
therapy technicians observing prior to project implementation. The coordinator also
supervised two random sessions during the project implementation for quality control.
In addition to the three education approaches, electronic medical record (EMR)
changes were implemented. WB use was documented in the EMR by the RNs, LPNs and
group technicians. An order for WBs to be used first-line was placed for patients with (a)
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a Generalized Anxiety Disorder Score 7-item (GAD-7) (Spitzer, Kroenke, Williams, &
Lowe, 2006) scale of 3 or higher, (b) a Brøset Violence Checklist (BVC) (Almvick &
Woods, 1999) score of 1 or higher, and/or (c) insomnia complaints.
A summary of the education and staff expectations (see appendix J) was hung in
three different areas in the central staff station and emailed to staff upon implementation
and half-way through the 90-day time period. Following current recommendations, the
staff was informed to offer patients a blanket weighing at least 10 percent of the patient’s
body weight (Ackerley et al., 2015). If an indicated weight was unavailable, staff was
educated to offer the patient the next available heavier option. If that size was not
available, a blanket weighing less than 10 percent of the patient’s body weight could be
offered as a last resort. A Patient Weight/Weighted Blanket Guidelines (Appendix K)
sign was hung in a central staff area and included in the staff educational sessions.
Patients were encouraged to use the blankets for at least 15 minutes before requesting a
PRN medication or a different intervention. If patient and staff safety became a concern
medication was used based upon staff judgment.
Measurement of the demographic data and PICOT question outcomes was
accomplished by an EMR audit. After implementation of the staff educational session
and EMR changes, a two-week wait period occurred. The EMR audit was conducted by
the DNP Project Coordinator and the facility’s Policy Officer. Data regarding the
quantity of PRN medication administered for anxiety, agitation, and insomnia were
collected for each 90 day period. In addition, the staff’s attitude and beliefs regarding WB
use was measured by a five question pre-and post- survey developed for the purpose of
this DNP Project (Appendix L). All 14 staff members that attended the educational
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sessions completed the pre-survey, while 13 staff members completed the post-survey.
Surveys were matched with an individual code, so comparisons could be made.
Ethical Considerations
South Dakota State University’s Institutional Review Board (IRB) approval was
not needed because the project was a quality improvement project (Appendix M). The
project facility did not have an IRB or a nursing research council, so this approval was
not needed. The facility setting’s key stakeholder fully supported this project (Appendix
N). Patient personal information was not included in the data collection and all
information was kept confidential.
Results
Table 4 shows the total quantity of PRN medications and mean quantity of PRN
medications given per patient for anxiety, agitation, and insomnia. The mean of the total
number of PRN medications given per patient was relatively the same for the intervention
group and comparison group, along with the means for PRN medications given per
patient for each symptom. This project compared quantity of PRN medications before
and after the introduction of WBs. Based on this comparison (comparison group = 652
medications; mean/patient of 5.3 medications; intervention group = 499 medications;
mean/patient of 5.4 medications), there appears to be no clinically significant difference
between the two groups.
A logistic regression analysis was completed by an SDSU statistician and used to
determine the odds of group (comparison or intervention), gender, MH diagnosis,
presence of severe mental illness, age, or length of stay impacting whether any PRN
medication was administered or not, keeping all of the independent variables the same.
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Length of stay showed statistical significance in increasing the odds of a patient receiving
a PRN medication for all 3 symptoms (Tables 5, 6, 7). Presence of severe mental illness
showed statistically significant increased odds of receiving a PRN medication for
agitation (Table 6). Presence of severe mental illness was defined as being diagnosed
with bipolar current episode (CE) depressed, bipolar CE manic, bipolar 2, psychotic
disorder not otherwise specified (NOS), and schizophrenia/schizoaffective. In contrast,
group, gender, MH diagnosis, presence of severe mental illness (except for agitation), and
age did not significantly affect the odds of a patient receiving PRN medication for any of
the symptoms.
A two related samples Wilcoxon Signed Rank Test was used to determine if there
were significant differences between pre-and post- survey results in staff attitude and
beliefs. Significance of comparison of each answer from pre to post was set at p = < .05.
Of the five questions, all showed favorable improvement; however, question 2 (how often
do you believe staff are appropriately offering weighted blankets to patients) was the only
question to show a significant difference from pre- to post-survey (z = 2.00, p = .046).
Discussion
Barriers and Limitations
Barriers were present within the process of this project. Staff changes occurred
that influenced patient teaching on WB in group therapy sessions and admission
numbers. The setting had an NP who changed employment after the staff educational
sessions. This caused a change in what the facility considered to be full patient capacity.
With 15 beds, usually the facility can have up to 15 patients at one time; however, the
maximum capacity number changed to 10 due to the decrease in available providers.
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Mid-way through project implementation one of the two group technician changed
employment and the other was injured and absent for the remainder of the implantation
period. This created nursing staff entering the group technician role and an increase in
RNs from other units to step into the nursing roles. Also, in the last month of the
implementation period, the clinical director/psychiatrist became no longer employed at
the facility.
Within the project, limitations were present. The inability to chart WB use in the
EMR during the comparison time period created the inability to compare WB use during
the comparison time period and the intervention time period. The varying degrees of
mental illness severity also created a limitation in which these patients may have required
PRN medications to maintain safety on the unit. Five of the 19 direct care staff did not
attend the face-to-face training sessions, leading to possible inconsistencies with patients
being offered WBs. The 90-day implementation time period occurred during two major
holiday seasons, which could have impacted patient census on the unit as well as
symptom severity due to increased stress.
Impact, Sustainability, and Recommendations
Although this project did not show WBs having a significant impact on the
quantity of PRN medications given for anxiety, agitation, and insomnia, the project
setting could have still been impacted by the intervention. For example, the staff survey
showed an increase in the belief that staff were appropriately offering WBs to patients
after implementation of the treatment. With 81% of patients being offered a blanket
during the intervention period, it appears that staff is offering the blankets frequently and
they are being used by patients.
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The stakeholder remains invested in the creation of facility-wide WB policy. The
staff showing interest in the WBs and the low risk associated with blanket use indicates
the need for policy. Sustainability of this project will be led by the facility’s nursing
shared governance education council. This group will work to create a WB policy to be
implemented hospital wide for patients experiencing anxiety, agitation, and insomnia.
The captain of this council is the hospital’s nurse educator, who already has included WB
education into the inpatient nursing monthly newsletter and will continue to do this. The
nurse educator will also add WB education into the new hire orientation. (M. Brent,
personal communication, March 25, 2020).
Further recommendations include conducting research with a longer time-frame,
larger sample number, and homogenous MH diagnoses and length of stay to determine if
WBs reduce the frequency of PRN medications administered in this setting. Other patient
outcomes to examine would be reduction in restraint/seclusion incidents, patient
satisfaction, WB use after hospitalization, and increased scheduled medication
compliance. In addition, further helpful studies include hospitalized patients with nonMH diagnosis and elderly patients.
Conclusion
In the inpatient MH setting, patients have increased risk for experiencing anxiety,
agitation, and insomnia that can hinder successful inpatient treatment and prolong
hospitalization. Although commonly used to minimize these symptoms, PRN
medications can increase patients being exposed to risks and their benefits are not certain.
WBs provide a safe alternative to additional PRN medications, which increases patient
safety and lowers the risk associated with these medications.
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Table 1
Gender (Number and Percent)a

a

Comparison group
(n = 124)

Intervention group
(n = 92)

Male

55 (44%)

40 (43%)

Female

69 (56%)

52 (57%)

No significant differences with Chi-square (p = .898)
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Table 2
Patients Categorized by MH Diagnosis (Number and Percent)a
Comparison group
(n = 124)

Intervention group
(n = 92)

p

13 (10%)

12 (13%)

.733

Bipolar 1 CE manic

4 (3%)

6 (7%)

.254

Bipolar 2

7 (6%)

6 (7%)

.789

76 (61%)

48 (52%)

.180

Generalized anxiety disorder

2 (2%)

2 (2%)

.762

Psychotic disorder NOS

7 (6%)

10 (11%)

.159

15 (12%)

9 (10%)

.593

MH diagnosis
Bipolar 1 CE depressed

Depression

Schizophrenia/schizoaffective

Note. CE = Current Episode; MH = Mental Health; NOS = Not Otherwise Specified
a
No significant differences with Chi-square
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Table 3
Age Categories in Years (Number and Percent)a
Comparison group
(n = 124)

Intervention group
(n = 92)

18-29

54 (44%)

40 (43%)

30-39

27 (22%)

13 (14%)

40-49

13 (10%)

15 (16%)

50-64

25 (20%)

23 (25%)

5 (4%)

1 (1%)

Age categories

65 and up
a

No significant differences with Chi-square (p = .084)
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Table 4
Total Quantity of PRN Medications and Mean Quantity of PRN Medications Per Patient
Comparison group
(n = 124)

Intervention group
(n = 92)

No. doses

Mean no.
doses/patient

No. doses

Mean no.
doses/patient

For anxiety

238

1.9

187

2

For agitation

226

1.8

134

1.4

For insomnia

188

1.5

178

1.9

Total

652

5.3

499

5.4
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Table 5
Logistic Regression Analysis: PRN Anxiety Medications

Co-efficient

p

Explanation of
co-efficient

Increased % of
odds of receiving
a PRN anxiety
medication

Group

-.441

.120

.643

35.7%

MH diagnosis

-.010

.091

.990

1%

SMI vs. not SMI

-.291

.329

.747

25.3%

Age

.005

.606

.995

.5%

Length of stay

.090

.012

1.094

9.4%

Gender

.056

.846

1.058

5.8%

Note. SMI = Severe Mental Illness

WEIGHTED BLANKETS

24

Table 6
Logistic Regression Analysis: PRN Agitation Medications

Co-efficient

p

Explanation of
co-efficient

Increased % of
odds of receiving
a PRN agitation
medication

Group

-.441

.120

.643

35.7%

MH diagnosis

-.065

.558

.937

6.3%

SMI vs. not SMI

1.015

.006

2.759

176%

Age

.007

.562

1.007

.7%

Length of stay

.258

.000

1.295

29.5%

Gender

-.295

.420

.744

25.6%

Note. SMI = Severe Mental Illness
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Table 7
Logistic Regression Analysis: PRN Insomnia Medications

Co-efficient

p

Explanation of
Co-efficient

Increased % of
odds of receiving a
PRN insomnia
medication

Group

-.441

.120

.643

35.7%

MH diagnosis

-.094

.299

.910

9%

SMI vs. not SMI

-.210

.483

.810

19%

Age

.002

.858

1.002

.2%

Length of stay

.10

.004

1.111

11.1%

Gender

.373

.198

1.452

45.2%

Note. SMI = Severe Mental Illness

WEIGHTED BLANKETS

26
Appendix A

Johns Hopkins Evidence Based Practice Model
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Appendix B

Johns Hopkins Evidence Based Practice Model Copyright
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Appendix C

PRN Medications and Doses Listed by Indication for Use
Anxiety
Alprazolam (Xanax) 0.5 mg PO every 8 hours
Clonazepam (Klonopin) 1-2mg PO every 12 hours
Diazepam (Valium) 5 mg PO every 6 hours
Hydroxyzine pamoate (Vistaril) 50mg PO every 12 hours
Lorazepam (Ativan) 0.5-2 mg PO every 4 hours
Agitation
Diphenhydramine (Benadryl) 50 mg PO or IM every 4 hours
Lorazepam (Ativan) 0.5-2 mg PO or IM every 4 hours
Haloperidol (Haldol) 5mg PO or IM every 12 hours
Olanzapine (Zyprexa) 5-10 mg PO or IM every 12 hours
Ziprasidone (Geodon) 40 mg PO or 20 mg IM every 12 hours
Insomnia
Diphenhydramine (Benadryl) 50 mg PO every 4 hours
Mirtazapine (Remeron) 7.5-15 mg PO at bedtime
Melatonin 1mg-5mg PO at bedtime
Quetiapine (Seroquel) 25 mg PO at bedtime
Temazepam (Restoril) 15 mg PO at bedtime
Trazodone (Desyrel) 50 mg PO at bedtime
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Appendix D
Staff Education Outline

Know
What do I think I know about
weighted blankets?

Want
What do I want to know about
weighted blankets?

Learn
What did I learn about weighted
blankets?

1. Split staff into groups of 2-3 and give each group a handout of the above chart.
2. Explain that they are to fill out each section and have 15 minutes
▪ For the third section they may use the brochure and posters,
credible .org web-sites, or provided journal articles
3. After the charts are completed, meet back as a large group and share answers and
discuss findings
4. The DNP Coordinator will then explain the following
o How WBs work
▪ Sympathetic motor changes
▪ Using in low-lit rooms for at least 15 minutes
▪ Can wrap up in them while sitting, laying with blanket on top
▪ At least 10% of body weight, heavier is safe and can be more
effective
o WBs can reduce anxiety, agitation, and insomnia in the inpatient setting
o Medications can be harmful due to side-effects, poly pharmacy and often
are not prescribed when the patient leaves the inpatient setting
o Trying WB first before other treatments (when safe) will be how anxiety,
agitation, and insomnia are treated
o Patients with a GAD-7 of 3 or higher will have order triggered for WB
used first for anxiety symptoms
o Patients with BVC score of 1 or higher can have a nursing order put in for
use of WB first for agitation (when safe)
o Patient with complaints of insomnia can have nursing order put in for use
of WB first for insomnia
o Charting that a WB was used is important and will be on the BVC
intervention tab in the EMR
o Group therapy sessions regarding WB use will be conducted 3 times/week
o Brochures will be given to patient in their welcome packets
o Posters will be hung around the unit
o Patients may ask how they can make their own WBs, give them the WB
Sewing Instructions handout (Appendix O) or refer to the facility’s
occupational therapy department
o Ask staff why they think WBs are important in the patient setting and any
questions/issues they have or foresee with this treatment change
o Remind staff that weekly emails from the DNP Project Coordinator will
be sent to offer support and answer questions
o DNP Coordinator will give contact information if questions/issues arise
during the process
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Appendix E
Emails to Staff

Andela, Catherine T - SDSU Student
Mon 11/11/2019 5:25 PM

Hello all!
Thank you so much for all that attended the trainings. It truly means a lot and I hope
that you enjoyed the education. At the end of this email will be the "Key Points" to
remember for those that could not attend and for all of us to remember. I have also
hung up the "Key Points" in the nurses station and the providers have a copy. I know
this may be an adjustment to offer weighted blankets first for anxiety, agitation, and
insomnia and to offer them without medications. I do think being pro-active will be
important. If you see patients getting anxious or ramping up, going to them and pointing
out what you see and suggesting them try a weighted blanket before the anxiety and/or
agitation becomes too much could lead to more successful blanket treatment. Thanks
again everyone! The project is underway and I couldn't be happier to be joining with you
all for this. Please talk to me with any questions/comments.
Cathy
Key Points
1. Weighted blankets should be offered first for patients with anxiety, agitation,
and insomnia.
2. Patients should use the weighted blanket for a minimum of 15 minutes before
requesting a different intervention or PRN medication.
3. Patients can use the blanket in their room by laying covered with the blanket,
sitting with blanket on lap or wrapped around, or in the group room if the group
technician approves this. Weighted blankets are not to be used in the day room.
4. Weighted blankets will be put in patients room that have a GAD-7 of 3 or higher,
a BVC of 1 or greater, and/or insomnia complaints.
5. Every weighted blanket that is used by a patient must have a nursing order for
weighted blanket use entered.
6. Chart weighted blanket use and effectiveness daily (under the anxiety tab).
7. The information on the brochures and posters should be pointed out to patients.
8. Patients wondering about how to make their own weighted blanket should be
given the hand-out with step-by-step directions on how to make their own
weighted blankets.
9. 10% or higher weighted blanket weight should be offered to patients. If the
appropriate 10% weight is not available then the next size up should be offered.
If the next size up is not available, then the weight lower than 10% can be
offered.
Andela, Catherine T - SDSU Student
Mon 11/11/2019 5:30 PM

Group Technicians,
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Thank you both for your help with the patient education piece of this project. I have
attached the 2 group outline that I have created, along with sewing instructions for
those that may ask about this. Go ahead and create your own groups as well.
Remember to implement at least 3 groups about weighted blankets/week. More would
be even better!
There was also an idea to have a group teaching patients to make their own weighted
lab blankets, which Deb said she was OK with. Patients are also allowed to bring their
weighted blankets to group therapy sessions that are in the group room. Please let me
know as questions come up or what groups you are finding are helpful.
Thanks,
Cathy
Andela, Catherine T - SDSU Student
Wed 11/20/2019 8:03 PM

Just wanting to check in with how the weighted blankets being offered first is going.
Anything you have found that is difficult or not working? Thank you again for your
commitment with this. I hope our patients find symptom relief from this intervention.
Education tidbit of the week: Weighted blankets are considered a sensory based
intervention. They are often used with autistic children that have sensory
processing dysregulation. Do you know who else often has sensory
processing dysregulation? Patients with schizophrenia and bi-polar mania. These
patients often enter the inpatient unit in severe dysregualation. They will often be
hesitate and even fearful to try a sensory based intervention (like weighted blankets)
when they are dysregulated, however the hospital is a very safe setting for them to try
this intervention. The more they try sensory interventions, they more used to them they
will get and will find sensory regulation. So, offer weighted blankets to these groups of
patients as well! They may only be able to use them for 15 minutes, but the more they
are introduced to them the more they may find benefits (Björkdahl, Perseius,
Samuelsson, & Lindberg, 2016; Wiglesworth & Farnworth, 2016).
I've attached 2 articles that talk about sensory rooms that include multiple sensory
based interventions that are being used in the inpatient setting.
Thank you everyone and let me know if you have questions or concerns!
Cathy
Andela, Catherine T - SDSU Student
Mon 11/27/2019 7:15 PM

Hello!
I am wanting to get some feedback from what you are finding that patients like or do
not like about the blankets. Are you finding some of them not wanting to try the
blankets first and becoming more symptomatic? Anyone have ways of talking to
patients to get them to try the WBs? How do you feel the brochures and poster help?
Thank you all for your help with this! Keep offering the WB first before medications for
anxiety, agitation, and insomnia. Please reach out to me with questions or concerns!
Cathy
Andela, Catherine T - SDSU Student
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Wed 12/4/2019 11:25 AM

I just wanted to check in and see how things are going. I have heard great feedback!
Anyone notice weighted blankets helping patients when you didn't expect it to? Is it
going well having them use the blankets in group if they want? Thank you for helping
me implement this project! A few reminders: have the patients use the blankets for a
minimum of 15 minutes. They can use the blankets by laying with them, wrapping them
around, reading or listening to music while under the blanket, or however they are
comfortable with their feet off the ground and blanket in use. 10% or higher for the
weight is best.
Educational point: A study showed that autistic children did not show improved sleep
through testing various physical conditions. However, a significant number of children
and their parents perceived that the weighted blanket improved their sleep and the
children felt more rested. So, at times our patients may not show us signs that the
blankets help, but asking them their opinion is important to understand
their perception of how the blanket is beneficial.
Thanks again! I appreciate you all!
Cathy
Andela, Catherine T - SDSU Student
Fri 12/13/2019 3:24 PM

Just wanting to check-in and be available for any questions about the weighted
blankets! Anyone have experiences in which the blankets were effective? Do you feel
the brochure and posters are helpful? Any tips to share with others on how to educate
patients about the benefits of weighted blankets?
Educational point: In order for blankets to be effective for aggression, I believe being
proactive is the key. Pointing out to patients (when appropriate and safe) that they
seem to be irritable and maybe a blanket would help or saying "do you think a weighted
blanket would help your mood right now?" are ways to introduce the intervention.
Being forward with our questions, yet gentle to not upset the situation more can help
patients gain awareness and be open to trying a potentially helpful coping skill.
Thanks everyone for your help with this project!
Cathy
Andela, Catherine T - SDSU Student
Tue 12/23/2020 7:15 PM

Just wanting to check in and remind everyone to review the key points that are posted!
You all are doing great with offering the blankets and providing great care to the
patients. Please continue to offer the blankets first for anxiety, agitation, and insomnia. I
encourage you to talk time to talk to the patients about the calming effects that the
WBs can offer. The more you all talk highly of them, the more the patients may be
interested in trying them. During the holidays especially patients may feel overwhelmed
and emotional. Encouraging them to try the WB may help with these symptoms.
Thanks! Cathy
Andela, Catherine T - SDSU Student
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Tue 1/6/2020 2:42 PM

Hello,
I will be on the unit tomorrow if anyone has questions, concerns, and/or feedback.
Thanks again for your support!
Cathy
Andela, Catherine T - SDSU Student
Sun 1/13/2020 8:16 PM

Hello! Just wanting to check in and let you know I am available or questions/comments.
I have heard from some of you that you feel the WBs are helpful and that patients are
responding well to the brochures and posters. Please continue to offer the WBs first and
talk positively about their benefits to the patients.
Thanks!
Cathy
Andela, Catherine T - SDSU Student
Sun 1/26/2020 7:10 PM

Hello! I hope all is going well with the weighted blanket project! Anyone have any
success with how to talk to patients about trying the blankets when they are insistent
on having a medication first? Do you see patients using them during the day and not just
at night? Do you notice any diagnosis in which the weighted blankets do not seem as
effective?
Remember that there is science behind how the weighted blankets work. They are
considered a form of deep pressure stimulation (DPS). DPS has been show to work on
receptors in the brain. Specifically the sympathetic nervous system (flight or fight) and
the parasympathetic nervous system (vagus nerve). DPS lowers the sympathetic nervous
system response and increases the parasympathetic response. Explaining this process to
the patients is not only important for them to understand why weighted blankets work,
but for them to be more excepting of trying the blankets instead of medications.
Andela, Catherine T - SDSU Student
Tue 2/5/2020 8:01 AM

Hello all!
I hope that you are all doing well and that the weighted blanket project is creating
better patient outcomes! Just a reminder to keep offering the blankets first and
remember to put the order in for the blankets. I am also attaching some group ideas, as
I have heard that various staff are leading groups. I would like a group about weighted
blankets 3 times/week, but if more than that happens that is great! These are just ideas
for groups-- if anyone ends up doing different weighted blanket groups please let me
know how they went! Thanks for your help with this!
Cathy
Also here are the key points reminder:
Weighted Blankets Quality Improvement Project
1. Weighted blankets should be offered first for patients with anxiety, agitation,
and insomnia.
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2. Patients should use the weighted blanket for a minimum of 15 minutes before
requesting a different intervention or PRN medication.
3. Patients can use the blanket in their room by laying covered with the blanket,
sitting with blanket on lap or wrapped around, or in the group room if the group
technician approves this. Weighted blankets are not to be used in the day room.
4. Weighted blankets will be put in patients room that have a GAD-7 of 3 or higher,
a BVC of 1 or greater, and/or insomnia complaints.
5. Every weighted blanket that is used by a patient must have a nursing order for
weighted blanket use entered.
6. Chart weighted blanket use and effectiveness daily (under the anxiety tab).
7. The information on the brochures and posters should be pointed out to patients.
8. Patients wondering about how to make their own weighted blanket should be
given the hand-out with step-by-step directions on how to make their own
weighted blankets.
9. 10% or higher weighted blanket weight should be offered to patients. If the
appropriate 10% weight is not available then the next size up should be offered.
If the next size up is not available, then the weight lower than 10% can be
offered.
Andela, Catherine T - SDSU Student
Thu 2/11/2020 8:30 PM

Hello!
I hope everyone is doing well! I wanted to check in and remind you with some of the
staff changes that are occurring, it is important to inform float staff of WBs being
offered first for anxiety, agitation, and insomnia. Also pointing out the key points for
them to reference will be helpful. For those of you stepping into the group technician
roll, please make sure to include WB groups and education. Thank you again for all of
your support!
Cathy
Andela, Catherine T - SDSU Student
Thu 2/20/2020 11:11 AM

Hello!
Do you think the weighted blankets are helping our patients? I got some great feedback
from some of you regarding manic patients struggling with the blankets. Thank you so
much for providing that information- it is helpful when I will talk about limitations in my
paper. Anyone have good or bad experiences with the blankets being used instead of
medications? Please continue to offer them first! I will be on the unit on March 3 if any
of you have any questions. Also next week I will be sending the same survey that some
of you took last November for you to take again. Thanks so much for your time and
effort with this project!
Cathy
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Appendix F
Weighted Blanket Poster
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Appendix G
WB Brochure
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Appendix H
Group Therapy Session 1 Outline

Know
What do I think I know
about weighted blankets?

Want
What do I want to know
about weighted blankets?

Learn
What did I learn about
weighted blankets?

1. Intro: we are trying new and exciting treatments for symptoms you feel while in
the hospital. Weighted blankets may be able to help with anxiety, agitation, and
sleeping issues. Has anyone tried a weighted blanket? What did you think of it?
Weighted blankets are safe and if you feel comfortable with using them, we
welcome you to try them as a first intervention when you feel they may help.
2. Using the white board, make this chart so all patients are able to see clearly.
3. First ask the patients what do they think they know about weighted blankets.
a. Answers may include that they lower anxiety, help you sleep, can be
expensive.
b. Help patients come up with answers if they are struggling by asking them:
i. Have they ever tried a weighted blanket?
ii. What does it feel like to be hugged?
iii. Describe what a weighted blanket looks like.
4. Next ask the patients what they want to know about weighted blankets.
a. Answers may include where can I a weighted blanket, when should I use a
weighted blanket, how heavy of a blanket should I use?
b. Guide the patients by asking if they have wondered:
i. What does a weighted blanket feel like?
ii. Can I only use a weighted blanket during the night?
iii. How much are weighted blankets?
iv. Can I make my own weighted blanket?
v. Is there a small version of a weighted blanket?
vi. How do I clean a weighted blanket?
5. Finally, using the brochures, poster, and nurse/group therapy leader’s knowledge
answer questions that patients may have had. Go over the information on the
poster and in the brochures. Then fill out the last column by asking patients what
they have learned about weighted blankets.
a. You may include information they learned prior to this group therapy
session through conversations with peers and staff on the unit.
End the group by emphasizing the information collected in the chart. Encourage
patients to try a weighted blanket first when they are feeling anxious, agitated,
and having trouble sleeping. Remind them the importance of awareness and that
journaling after using a blanket may help them realize how the blanket helped or
did not help.
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Appendix I
Group Therapy Session 2 Outline

1.

Explain that you are inviting the patients to go to their rooms and use a WB for
15 minutes. They can wrap up with the blanket and read, lay down with the
blanket covering them, or use the blanket how they feel would be comfortable.
Their room lighting should be dim and noise-level low. They are welcome to
listen to music (if appropriate) with their blanket; however, quiet and calming
music should be used.

2. Invite the patients to meet back in the group room after the 15 minutes and
discuss what the patients felt. Questions to focus on include symptom relief of
anxiety, agitation, and insomnia. Ask the patient what they felt worked and what
didn’t. Ask the patients if they feel a WB would help them in the future and how
they will ask to use one.
3. End the session by asking if they have any questions and reminding them to try
and use a WB first when feeling symptoms of anxiety, agitation, and insomnia.
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Appendix J

Educational Summary and Staff Expectations
1. Weighted blankets should be offered first for patients with anxiety, agitation, and
insomnia.
2. Patients should use the weighted blanket for a minimum of 15 minutes before
requesting a different intervention or PRN medication.
3. Patients can use the blanket in their room by laying covered with the blanket,
sitting with blanket on lap or wrapped around, or in the group room if the group
technician approves this. Weighted blankets are not to be used in the day room.
4. Weighted blankets will be put in patients room that have a GAD-7 of 3 or higher,
a BVC of 1 or greater, and/or insomnia complaints.
5. Every weighted blanket that is used by a patient must have a nursing order for
weighted blanket use entered.
6. Chart weighted blanket use and effectiveness daily (under the anxiety tab).
7. The information on the brochures and posters should be pointed out to patients.
8. Patients wondering about how to make their own weighted blanket should be
given the hand-out with step-by-step directions on how to make their own
weighted blankets.
9. 10% or higher weighted blanket weight should be offered to patients. If the
appropriate 10% weight is not available then the next size up should be offered. If
the next size up is not available, then the weight lower than 10% can be offered.
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Appendix K

Patient Weight/Weighed Blanket Guidelines
Patient Weight Range
75 – 125 pounds
126 – 175 pounds
176 – 225 pounds
226 pounds and up

Recommended Blanket Weight*
(10% of body weight)
10 pounds
15 pounds
20 pounds
25 pounds

*If indicated blanket weight is not available or patient prefers increased weight, it is safe
to use the next heavier option. If the heavier option is not available, patients should be
offered a lighter option.
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Appendix L
Staff Attitudes and Beliefs Survey

1. What is your attitude towards the use of weighted blankets in the inpatient
mental health setting?
Very positive
Somewhat positive
Neutral
Somewhat negative
Very negative
2. How often do you believe staff are appropriately offering weighted blankets to
patients?
Extremely often
Very often
Somewhat often
Not very often
Not at all
3. How effective is a weighted blanket on lowering patient anxiety compared to
medications?
Extremely effective
Very effective
Somewhat effective
Not so effective
Not at all effective
4. How effective is a weighted blanket on lowering patient agitation compared to
medications?
Extremely effective
Very effective
Somewhat effective
Not so effective
Not at all effective
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5. How effective is a weighted blanket on improving patient sleep quality compared
to medications?
Extremely effective
Very effective
Somewhat effective
Not so effective
Not at all effective
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Appendix M
SDUS IRB
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Appendix N
Stakeholder Project Support Letter
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Appendix O
WB Sewing Instructions

www.theisaacfoundation.org

Weighted Blanket Instructions
Weighted Blanket Materials:
•

1 pound of Quality Poly Pellets per 10 pounds of weight for the user, plus
one extra pound
Fabric of your choice
• 2 yds. of fabric for the top of the blanket
• 2 yds. of fabric for the bottom of the blanket
• Thread
• Scissors
• Measuring Tape
• Ruler
• A small scale
• Pins
• Sewing machine
Assembling your Weighted Blanket:
1. Determine the size. If your blanket is going to be portable, you will want to
make it smaller than the one that goes on your bed. The materials above will
make a blanket to fit a twin bed (40” x 76”).
2. After you have your blanket size ready, place the fabrics right sides together.
3. Measure 2 inches in on two of the long sides and 1.5 of the short sides,
leaving one side open for adding your pellets. Helpful Hint: Iron in a crease
for marking rows and columns and use the crease for your stitching line. Use
a 6 by 12 inch quilting ruler for measuring rows and then fold the fabric and
press through the layers with a shot of steam.
4. Sew on the lines, and then turn the fabric inside out. Iron the edges so they
are nice and crisp!
5. Prepare for adding the poly pellets.
6. Measure out a grid for the remaining area of the blanket. Since we are taking
off 4” from each side for an edge, we will have a weighted area of 36” x 72”.
7. Divide the area into even squares, making as neat a grid as you can. If
making 6” by 6” square, we will have a perfect six squares across and twelve
squares up!
8. Divide out all of the pellets into the right sized portions. To do that, just
follow this handy formula: Blanket weight in ounces/number of squares you
have = number of ounces per square. Remember that 16 US oz. = 1 lb. You
can have someone help you measure them out for you as you go!
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9. Sew along the vertical lines to make channels six inches apart from each

other. This is where you are going to pour the pellets.
10. Once all of the channels are ready, pour the proper amount of fill for each

square into each of the six channels. Shake them a little so they settle to the
bottom.
11. Measure six inches from the bottom seam and sew a straight line across the
fabric, sealing up that line of weighted squares.
12. Repeat steps seven and eight until you have finished the last row of squares
at the top.
Fold in the two inches of fabric that are left over, then stitch that shut. This will
seal up the top row of weighted squares, and you now have a personal,
homemade blanket!
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Appendix P

Copyright Permission from Isaac Foundation

RE: Copyright permission for DNP Project
Anna <anna@theisaacfoundation.org>
•

Thu 10/10/2019 2:31 PM
To:
'Cathy Andela-Ruth' <cathyandela@hotmail.com>

Hi Cathy
We think it is wonderful that you find this useful, please feel free to use it! Please let me know if
this email will suffice as permission or if you need an official letter
Thanks
Anna Williams
The Isaac Foundation
509-325-1515
TheIsaacfoundation.org
Facebook
Instagram

From: Cathy Andela-Ruth [mailto:cathyandela@hotmail.com]
Sent: Wednesday, October 9, 2019 9:32 AM
To: hello@theisaacfoundation.org
Subject: Copyright permission for DNP Project

Hello!
I am a Doctorate of Nursing Practice student and completing a quality improvement
project on the use of weighted blankets in the adult inpatient mental health setting. I
was wondering if I could get a copyright permission to use your “Weighted Blanket
Sewing Instruction” handout in my project to be included in the paper and also to give
to patients if they are wanting to learn how to make their own weighted blanket.
If this is ok, I would just need a letter back saying I have copyright permission to use this
handout. Thank you so much!
Cathy Andela-Ruth
SDSU DNP NP Student

